Novasep, which makes active pharmaceutical ingredients (API) on a contractual basis, said the accreditation “demonstrates the know-how, expertise and … safe handling of highly potent compounds” available at the facility.
SafeBridge certified the plant after an extensive review of the production operations and procedures in place at the plant’s R&D laboratories and manufacturing areas, as well as its quality control (QC) testing unit.
Rene de Vaumas, head of Novasep’s synthesis business, said the site provides a “combination of total synthesis, extraction, semi-synthesis and chromatographic purification” to pharma industry clients.